Visco Vision Inc. (6782.TW) Stock

6782.TW logo

Visco Vision Inc.

6782.TWTaiwan
Healthcare

Company profile

Visco Vision reported revenue of 4.22 billion TWD for fiscal year 2025, up 15.0% from fiscal year 2024, and net income of 887.07 million TWD. That is a net profit margin of 21.0% for fiscal year 2025. Our analysis of its filings shows revenue growing from 2.40 billion TWD in fiscal year 2023 to 4.22 billion TWD in fiscal year 2025, 32.7% a year on average.

What stands out

  • Asia brought in 67% of revenue by region in fiscal year 2025, up from 61% in fiscal year 2024; the company is based in Taiwan.
  • Revenue and net income in fiscal year 2025 were the highest of the last 5 fiscal years.

Figures from company filings; latest fiscal year ended December 31, 2025.

About Visco Vision Inc.

Visco Vision Inc. manufactures and sells silicone hydrogel contact lenses in Asia, Europe, and the Americas. It offers spherical, multifocal, toric, cosmetic, and color lenses. The company also provides medical and lease management services. Visco Vision Inc. was incorporated in 1998 and is based in Taoyuan City, Taiwan.

Largest shareholders

  • Taichung Bank Securities Investment Trust Co., Ltd.0.43%
  • Mackenzie Investments Corp. (United States)0.38%
  • RAM Active Investments SA0.03%

Share of the company, as of September 25, 2026

Leadership

  • Chongyi Li — Chairman of the Board, President & CEO
  • Sharon Cheng — Chief Financial Officer & Corporate Governance Director
  • Richard Yang — Chief Information Security Officer
  • Cang-Song Wu — Vice President
  • Pei Qing Zheng — Accounting Supervisor

How much revenue does Visco Vision make?

Visco Vision reported 4.22 billion TWD in revenue for fiscal year 2025, up 15.0% from 3.67 billion TWD in fiscal year 2024.

Where does Visco Vision make most of its revenue?

Asia: 67% of revenue by region in fiscal year 2025, followed by Europe (17%).

What companies are similar to Visco Vision?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Pegavision Corporation (6491.TW), Vizionfocus Inc. (4771.TW), St.Shine Optical Co.,Ltd. (1565.TWO), Icares Medicus, Inc. (6612.TWO).

How has Visco Vision's revenue by region changed?

Share of revenue by region in fiscal years 2024 and 2025: Asia, 61% and 67%; Europe, 19% and 17%; Taiwan, 13% and 11%; America, 7% and 5%.

How has Visco Vision's revenue changed over the last 5 fiscal years?

Revenue by fiscal year: FY2021, 1.96 billion TWD; FY2022, 2.78 billion TWD; FY2023, 2.40 billion TWD; FY2024, 3.67 billion TWD; FY2025, 4.22 billion TWD.

Company Information

SectorHealthcare
IndustryTargeted Healthcare Equipment
HeadquartersTaoyuan City, Taiwan
ExchangeTaiwan
TimezoneAsia/Taipei (CST)

Contact & Links

Address
No. 1, Xingye Street, Taoyuan City, 33341
Phone
886 3 359 6868
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Visco Vision Inc. (6782.TW)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/6782.TW

LinkedInLinkedInXXYouTubeYouTube